dxOmics
PrivateLast Round
Grant
Jul 17, 2025
Total Funding Raised
$2,000
Company Overview
dxOmics operates in Healthcare & Life Sciences and is based in Tübingen. Its latest recorded funding round was a Grant round in July 2025.
dxOmics is a biotechnology company that provides an AI-driven, cloud-enabled clinical decision support system for genome diagnostics and research, facilitating NGS analysis, interpretation of genetic variants, and report generation for rare genetic diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
dxOmics Comparables
Compare dxOmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Limbus Medical Technologies | 81% | |
| SeqOne | 78% | |
| Saphetor | 77% |
For institutional investors. Book with your work email.
dxOmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 17, 2025 | ||||
| Accelerator | Jun 24, 2025 | ||||
| Grant | Jun 3, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
dxOmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| L-Bank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2025
Received grant funding.
- Jun 3, 2025
$2K grant round led by L-Bank.
For institutional investors. Book with your work email.
dxOmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about dxOmics's valuation, stock price, and market status.
Is dxOmics a public or private company?
dxOmics is a private company.
What is the current stock price of dxOmics?
dxOmics is a private company, so its shares have no public market price. Caplight tracks dxOmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is dxOmics worth (valuation)?
Valuation information for dxOmics is not publicly available.
Can I buy dxOmics stock?
dxOmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was dxOmics's last funding round?
dxOmics's most recent funding round was Grant on July 17, 2025.
Who are the main investors in dxOmics?
Key investors in dxOmics include L-Bank.
Will dxOmics IPO soon?
No public IPO plans have been announced for dxOmics.
How can I track dxOmics secondary market activity?
Caplight tracks bids, offers, and trades in dxOmics's shares on secondary markets.